American International Group, Inc. Neuronetics, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $26,478 - $47,001	-12,669 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $2,533 - $4,031	-892 Reduced 6.58%	12,669 $38,000
Q4 2021 Feb 11, 2022	SELL	$3.87 - $6.59 $1,571 - $2,675	-406 Reduced 2.91%	13,561 $60,000
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $174 - $435	-28 Reduced 0.2%	13,967 $92,000
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $142,049 - $241,413	13,995 New	13,995 $224,000
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.61 $11,134 - $20,611	-7,897 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.28 - $4.5 $584 - $2,056	-457 Reduced 5.47%	7,897 $15,000
Q4 2019 Feb 05, 2020	BUY	$4.03 - $9.22 $310 - $709	77 Added 0.93%	8,354 $38,000
Q3 2019 Nov 08, 2019	SELL	$8.31 - $13.03 $481 - $755	-58 Reduced 0.7%	8,277 $69,000
Q2 2019 Aug 13, 2019	BUY	$9.0 - $17.2 $1,836 - $3,508	204 Added 2.51%	8,335 $104,000
Q1 2019 May 06, 2019	BUY	$13.6 - $19.58 $53,407 - $76,890	3,927 Added 93.41%	8,131 $124,000
Q4 2018 Feb 13, 2019	SELL	$16.0 - $31.84 $496 - $987	-31 Reduced 0.73%	4,204 $81,000
Q3 2018 Nov 09, 2018	BUY	$24.32 - $37.54 $102,995 - $158,981	4,235 New	4,235 $136,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $35.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.